Vaccine shortage will affect all eligible groups
The two private vaccine manufacturers — Serum Institute and Bharat Biotech — are required to supply 50% of vaccine produced to the Central government and the balance to State governments…
Category: Bharat Biotech International
Covaxin offers protection against double mutant (B.1.617) variant
A preprint of the study carried out by ICMR and Bharat Biotech researchers has been posted in biorXiv. Preprints are yet to be peer-reviewed and published in medical journals. So…
India sets a dangerous precedent with COVID-19 vaccination programme
A large percentage of those aged 18-44 years does not have the resources to pay for vaccines and hence will fall through the cracks. So, the States will have to…
Can vaccination of all adults slow down the second wave?
While Maharashtra is still reporting the most cases daily, there has been a slip dip in the last few days. It is a bit early to say if the second…
India promotes vaccine inequity in the midst of the pandemic
The April 19 announcement of the roll-out of vaccines in the third phase, wherein anyone above 18 years is eligible for vaccination, comes at a time when many States have…
Can Covaxin booster dose prolong protection?
In a meeting held on March 24, the Subject Expert Committee of the India drug regulator permitted Bharat Biotech to carry out a phase-2 trial of Covaxin wherein a booster…
180 deaths following COVID-19 vaccination reported in India
In all, 492 severe and serious AEFI have been classified by the AEFI Secretariat of the immunisation technical support unit (ITSU) at the Health Ministry. Classification has been completed for…
Health Ministry reveals the names of SEC members for vaccine approval
Names of the ten members Dr. Varsha Gupta, Professor, Department of Microbiology, Government Medical College Hospital, Chandigarh; 2) Dr. Archana Thakur, Medical Director, Professor and HOD (Microbiology), G.B. Pant Hospital,…
